Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

NCT00002618

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
Locations
  • Via Christi Regional Medical Center-Saint Francis Campus Wichita, Kansas, United States
  • MBCCOP - LSU Medical Center New Orleans, Louisiana, United States
  • Memorial Mission Hospital Asheville, North Carolina, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Completed

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

NCT01292135

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • CLL Research and Treatment Program New Hyde Park, New York, United States
  • Weill Medical College of Cornell University New York, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Completed

Interferon Alfa in Treating Children With HIV-Related Cancer

NCT00002621

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
Locations
  • Via Christi Regional Medical Center Wichita, Kansas, United States
  • MBCCOP - LSU Health Sciences Center New Orleans, Louisiana, United States
  • Tomorrows Children's Institute Hackensack, New Jersey, United States
  • Mission Saint Joseph's Health System Asheville, North Carolina, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

NCT00394693

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Northwestern University Medical School Chicago, Illinois, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
  • Hopital Lapeyronie Montpellier, France
View Trial Details
Completed

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

NCT00901147

Conditions
Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Angioimmunoblastic T-cell Lymphoma, Enteropathy- Type T-cell Lymphoma, +20 more
Locations
  • Hospital Universiti Kebangsaan Malaysia ( HUKM ) Kuala Lumpur, Malaysia
  • Subang Jaya Medical Centre Subang Jaya, Selangor, Malaysia
  • National Cancer Center Singapore
  • Singapore General Hospital Singapore
View Trial Details

Related conditions